• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用XGBoost模型及可解释性预测耐碳青霉烯类铜绿假单胞菌感染风险

Predicting carbapenem-resistant Pseudomonas aeruginosa infection risk using XGBoost model and explainability.

作者信息

Jiang Yan, Wang Hong-Wei, Tian Fang-Ying, Guo Yue, Wang Xiu-Mei

机构信息

Department of Nursing, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, China.

Shanxi Medical University, Taiyuan, 030000, China.

出版信息

Sci Rep. 2025 Jun 5;15(1):19737. doi: 10.1038/s41598-025-04028-x.

DOI:10.1038/s41598-025-04028-x
PMID:40473759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141430/
Abstract

The prevalence and spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global public health problem. This study aims to identify the risk factors of CRPA infection and construct a machine learning model to provide a prediction tool for clinical prevention and control. A total of 1949 patients with P.aeruginosa health care-associated infections (HAIs) were enrolled in this study. A total of 89 patients with CRPA infection and 89 patients with CSPA infection were matched 1:1. LASSO regression was used to screen the variables, and the XGBoost model was established (136 cases in the training set and 60 cases in the test set). Shapley additive explain (SHAP) method was used to explain the importance of variables. The area under the ROC curve (AUC) and calibration curve were used to evaluate the performance of the model. There were 89 cases of CRPA infection, and the CRPA infection rate was 4.57%. Respiratory tract was the most common source of infection, and ICU and hematology department were the high-risk departments. The AUC value of the XGBoost machine learning model in the training set was 0.987 (95%CI: 0.974-1.000), and the AUC value in the test set was 0.862 (95%CI: 0.750-0.974). The clinical decision curve also showed good results of the model. SHAP results showed that ICU admission, duration of central venous catheterization, use of carbapenems and fluoroquinolones were important factors for predicting CRPA infection. The XGBoost machine learning model is helpful for the early prevention and screening of CRPA infection in medical institutions. Infection control and clinical departments should carry out effective prevention and control for high-risk factors to reduce the occurrence of CRPA infection.

摘要

耐碳青霉烯类铜绿假单胞菌(CRPA)的流行和传播是一个全球性的公共卫生问题。本研究旨在确定CRPA感染的危险因素,并构建一个机器学习模型,为临床预防和控制提供预测工具。本研究共纳入1949例铜绿假单胞菌医疗保健相关感染(HAIs)患者。将89例CRPA感染患者和89例CSPA感染患者进行1:1匹配。采用LASSO回归筛选变量,建立XGBoost模型(训练集136例,测试集60例)。采用Shapley加法解释(SHAP)方法解释变量的重要性。采用ROC曲线下面积(AUC)和校准曲线评估模型性能。CRPA感染89例,CRPA感染率为4.57%。呼吸道是最常见的感染源,ICU和血液科是高危科室。XGBoost机器学习模型在训练集的AUC值为0.987(95%CI:0.974-1.000),在测试集的AUC值为0.862(95%CI:0.750-0.974)。临床决策曲线也显示了该模型的良好结果。SHAP结果显示,入住ICU、中心静脉置管时间、碳青霉烯类和氟喹诺酮类药物的使用是预测CRPA感染的重要因素。XGBoost机器学习模型有助于医疗机构对CRPA感染进行早期预防和筛查。感染控制和临床科室应对高危因素进行有效防控,以减少CRPA感染的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/6d78f05ed969/41598_2025_4028_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/1fd70a94117c/41598_2025_4028_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/a665cf1e172a/41598_2025_4028_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/c5bc87b0ea2f/41598_2025_4028_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/6d78f05ed969/41598_2025_4028_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/1fd70a94117c/41598_2025_4028_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/a665cf1e172a/41598_2025_4028_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/c5bc87b0ea2f/41598_2025_4028_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80a/12141430/6d78f05ed969/41598_2025_4028_Fig4_HTML.jpg

相似文献

1
Predicting carbapenem-resistant Pseudomonas aeruginosa infection risk using XGBoost model and explainability.使用XGBoost模型及可解释性预测耐碳青霉烯类铜绿假单胞菌感染风险
Sci Rep. 2025 Jun 5;15(1):19737. doi: 10.1038/s41598-025-04028-x.
2
Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.耐碳青霉烯铜绿假单胞菌引起的医源性感染的危险因素。
J Microbiol Immunol Infect. 2018 Jun;51(3):359-366. doi: 10.1016/j.jmii.2017.08.015. Epub 2017 Sep 6.
3
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.肠碳青霉烯耐药铜绿假单胞菌的流行情况、危险因素和分子流行病学。
Microbiol Spectr. 2021 Dec 22;9(3):e0134421. doi: 10.1128/Spectrum.01344-21. Epub 2021 Nov 24.
4
Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.胃肠道微生物群紊乱与 ICU 患者定植耐碳青霉烯类铜绿假单胞菌的风险。
Clin Infect Dis. 2019 Aug 1;69(4):604-613. doi: 10.1093/cid/ciy936.
5
[Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].[与耐碳青霉烯类铜绿假单胞菌相关的医院感染暴发评估]
Mikrobiyol Bul. 2013 Oct;47(4):619-27. doi: 10.5578/mb.6253.
6
Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study.意大利重症患者中耐碳青霉烯类肠杆菌科细菌和铜绿假单胞菌所致医院获得性感染的发生率:一项多中心前瞻性队列研究
Crit Care. 2025 Jan 17;29(1):32. doi: 10.1186/s13054-025-05266-1.
7
Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.台湾地区耐碳青霉烯类铜绿假单胞菌:患病率、危险因素及对感染结局的影响。
J Microbiol Immunol Infect. 2016 Feb;49(1):52-9. doi: 10.1016/j.jmii.2014.01.005. Epub 2014 Mar 21.
8
Carbapenem-resistant infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China.中国一家大型三级儿科医院重症患儿耐碳青霉烯类感染:流行率、危险因素及对结局的影响。
Front Public Health. 2023 Feb 9;11:1088262. doi: 10.3389/fpubh.2023.1088262. eCollection 2023.
9
[Clinical characteristics and risk factors of carbapenem-resistant infection in children].[儿童耐碳青霉烯类感染的临床特征及危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Nov 15;26(11):1169-1175. doi: 10.7499/j.issn.1008-8830.2407020.
10
Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.外科重症监护病房爆发耐碳青霉烯铜绿假单胞菌感染。
J Hosp Infect. 2010 Apr;74(4):350-7. doi: 10.1016/j.jhin.2009.10.024. Epub 2010 Feb 19.

本文引用的文献

1
Molecular epidemiology and carbapenem resistance mechanisms of isolated from a hospital in Fujian, China.从中国福建一家医院分离出的分子流行病学及碳青霉烯类耐药机制
Front Microbiol. 2024 Sep 5;15:1431154. doi: 10.3389/fmicb.2024.1431154. eCollection 2024.
2
Nationwide genome surveillance of carbapenem-resistant in Japan.日本全国范围内耐碳青霉烯类肠杆菌科细菌的基因组监测。
Antimicrob Agents Chemother. 2024 May 2;68(5):e0166923. doi: 10.1128/aac.01669-23. Epub 2024 Apr 2.
3
A comparative study of explainable ensemble learning and logistic regression for predicting in-hospital mortality in the emergency department.
一种用于预测急诊科住院死亡率的可解释集成学习与逻辑回归的对比研究。
Sci Rep. 2024 Feb 10;14(1):3406. doi: 10.1038/s41598-024-54038-4.
4
Genomic epidemiology and molecular characteristics of bla-positive carbapenem-resistant Pseudomonas aeruginosa belonging to international high-risk clone ST773 in the Gauteng region, South Africa.南非豪登地区携带 bla 阳性碳青霉烯类耐药铜绿假单胞菌国际高危克隆 ST773 的基因组流行病学和分子特征。
Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):627-640. doi: 10.1007/s10096-024-04763-5. Epub 2024 Jan 24.
5
Analysis of Risk Factors for Carbapenem Resistant Infection and Construction of Nomogram Model: A Large Case-Control and Cohort Study from Shanxi, China.碳青霉烯类耐药感染危险因素分析及列线图模型构建:来自中国山西的一项大型病例对照和队列研究
Infect Drug Resist. 2023 Nov 29;16:7351-7363. doi: 10.2147/IDR.S442909. eCollection 2023.
6
Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat.重症监护病房中耐碳青霉烯类铜绿假单胞菌作为一种新出现的全球威胁,会增加死亡率。
Int J Surg. 2023 Apr 1;109(4):1034-1036. doi: 10.1097/JS9.0000000000000184.
7
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.碳青霉烯类耐药铜绿假单胞菌和相关碳青霉烯酶(POP)的全球流行病学和临床结局:一项前瞻性队列研究。
Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9.
8
Risk Factors and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection.耐碳青霉烯类血流感染患者的危险因素及预后
Infect Drug Resist. 2023 Jan 19;16:337-346. doi: 10.2147/IDR.S396428. eCollection 2023.
9
Editorial: Current perspectives on : epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens.社论:关于多重耐药(MDR)病原体的流行病学、毒力及当代应对策略的当前观点
Front Microbiol. 2022 Jul 26;13:975616. doi: 10.3389/fmicb.2022.975616. eCollection 2022.
10
Carbapenem Resistant Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes.老年患者的碳青霉烯类耐药感染:抗菌药物耐药谱、危险因素及对临床结局的影响
Infect Drug Resist. 2022 Apr 29;15:2301-2314. doi: 10.2147/IDR.S358778. eCollection 2022.